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ENGLISH ABSTRACT 
Summary of Background data: There is limited scientific data concerning the use and outcome 
of medications used in management of disc herniation, both here in Sudan and worldwide at large, 
despite the multiple number of cases encountered and obvious use of these medications in 
contemporary clinical practice. 
Objective: To assess the clinical use and outcome of drugs used for the     management of 
intervertebral disc herniation (IDH) among Sudanese people. 
Method: A total of 270 eligible, consenting patients recruited from practices of orthopedic 
surgeons, neurosurgeons, neurologists, and physical and rehabilitation physicians throughout 
regions of Sudan referred to National Center for Neurological sciences and specialty referral unit 
of Ibrahim Malik Teaching Hospital, Khartoum throughout the study period had baseline 
interviews and later followed up with questionnaires after a period of 6 months. 150 patients were 
under retrospective study and 120 under prospective study. Clinical data were obtained at baseline 
from a physician questionnaire. Outcomes included patient-reported symptoms of leg and back 
pain, functional status, satisfaction, and social status. 
Results: The patients recruited received different IDH therapies, 77 patients received pure 
pharmacologic follow up therapy. Statistically insignificant QLA outcomes were obtained from 
both the general therapies, in retrospective study (p=0.214, pc=0.102) and prospective study 
(p=0.998, pc=0.000) and also in the pharmacologic stand alone therapy, retrospective study 
(p=0.284, pc=-0.181) and prospective study (p=0.472, pc=-0.117). Different types of analgesics 
and vitamins were the most commonly used medications and the outcome of their use showed 
statistically insignificant changes in the QOL of the patients.  
Conclusion: The different therapies used in management of IDH among Sudanese are relatively 
less effective and produce insignificant change in QOL of the patients, especially the 
pharmacologic stand alone therapy.  
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